Zobrazeno 1 - 10
of 82
pro vyhledávání: '"Zaid M. Abdelsattar"'
Autor:
Joseph F. Zywiciel, BS, Raymond A. Verm, MD, Wissam Raad, MD, Marshall Baker, MD, FACS, Richard Freeman, MD, MBA, Zaid M. Abdelsattar, MD, MS, FACS
Publikováno v:
JTCVS Open, Vol 18, Iss , Pp 221-231 (2024)
Objectives: Current National Comprehensive Cancer Network guidelines recommend definitive chemoradiation rather than surgery for patients with locally advanced clinical stage T3 and N2 (stage IIIB) lung cancer involving the chest wall. The data suppo
Externí odkaz:
https://doaj.org/article/3d3df513b12745c88fae2b2e610f3414
Autor:
Mohamed Gadelkarim, MD, Layan Alrahmani, MD, Celsa Tonelli, MD, Richard Freeman, MD, MBA, Wissam Raad, MD, James Lubawski, Jr., MD, Wickii T. Vigneswaran, MD, MBA, Zaid M. Abdelsattar, MD, MS
Publikováno v:
JTCVS Open, Vol 12, Iss , Pp 315-328 (2022)
Objectives: The coronavirus disease 2019 (COVID-19) pandemic has changed the landscape of professional activities, emphasizing virtual meetings and social media (SoMe) presence. Whether cardiothoracic programs increased their SoMe presence is unknown
Externí odkaz:
https://doaj.org/article/fe7b17356ea547c1971492f2c1b5b988
Autor:
Michael J. Littau, BA, Richard Freeman, MD, MBA, Wickii T. Vigneswaran, MD, MBA, Fred A. Luchette, MD, MSc, Marshall S. Baker, MD, MBA, Wissam Raad, MD, Zaid M. Abdelsattar, MD, MSc, Tyler Grenda, MD, MS, James Lubawski, MD, Maria Lucia L. Madariaga, MD
Publikováno v:
JTCVS Open, Vol 9, Iss , Pp 249-261 (2022)
Objectives: Stereotactic body radiation therapy (SBRT) is an established primary treatment modality in patients with lung cancer who have multiple comorbidities and/or advanced-stage disease. However, its role in otherwise healthy patients with stage
Externí odkaz:
https://doaj.org/article/c6fd2270517047a39b06700576f78279
Autor:
Mark Jaradeh, Wickii T. Vigneswaran, Wissam Raad, James Lubawski, Richard Freeman, Zaid M. Abdelsattar
Publikováno v:
The Annals of Thoracic Surgery. 114:2041-2047
Traditionally, neoadjuvant chemoradiation therapy is followed by resection in patients with locally advanced non-small cell lung cancer (NSCLC). The risks and benefits of this approach are not well defined in patients requiring a sleeve lung resectio
Publikováno v:
The Annals of Thoracic Surgery.
Autor:
Michael J. Littau, Corinne Bunn, Preston Kim, Sujay Kulshrestha, Celsa Tonelli, Zaid M. Abdelsattar, Fred A. Luchette, Marshall S. Baker
Publikováno v:
The American Journal of Surgery. 223:527-530
Few studies evaluate the efficacy of adjuvant radiotherapy (aXRT) in patients with retroperitoneal liposarcoma undergoing resection to histologically positive (R1) margins.We queried the National Cancer Database to identify patients undergoing R1 res
Autor:
Jacob Rattin, Fritzie S. Albarillo, Constantine Kanakis, Zaid M. Abdelsattar, Daneyal Syed, Amanda Harrington, Vijayalakshmi Ananthanarayanan
Publikováno v:
Journal of Clinical Microbiology. 61
Autor:
Jacob Rattin, Fritzie S. Albarillo, Constantine Kanakis, Zaid M. Abdelsattar, Daneyal Syed, Amanda Harrington, Vijayalakshmi Ananthanarayanan
Publikováno v:
Journal of Clinical Microbiology. 61
Read the full article for the answer.
Autor:
Raymond A. Verm, Zaid M. Abdelsattar
Publikováno v:
Journal of Thoracic Disease.
Publikováno v:
J Thorac Dis
BACKGROUND: The effect of marginal lung function on outcomes after lung resection has traditionally been studied in the context of open thoracic surgery. Its impact on postoperative outcomes in the era of minimally invasive lung resection is unclear.